| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/26/2005 | US6921761 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/26/2005 | US6921540 Hypotonic brines comprising mixtures of sodium, potassium, magnesium, calcium, chlorine and sulfates in water, used for prevention of inflammation of mucous membranes and for dissolving plugs in ears |
| 07/26/2005 | US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain |
| 07/26/2005 | US6921527 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2256609C 5-aroylpyrrol-2-ylmethylarene derivatives as inhibitors of prostaglandin g/h synthase |
| 07/26/2005 | CA2133439C Compounds useful for treating allergic and inflammatory diseases |
| 07/21/2005 | WO2005066410A1 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/21/2005 | WO2005066201A1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 07/21/2005 | WO2005066193A1 Levulose glucoselipid a analogue |
| 07/21/2005 | WO2005066156A1 Selective kinase inhibitors |
| 07/21/2005 | WO2005065063A2 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2005030251A8 Compositions and methods to accelerate hematologic recovery |
| 07/21/2005 | WO2005028513A3 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 07/21/2005 | WO2003105811A8 Controlled release compositions and methods for using same |
| 07/21/2005 | US20050159589 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 07/21/2005 | US20050159585 Forming acyl azide function on acid group of amino acid derivative, then transforming to isocyanate |
| 07/21/2005 | US20050159584 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159462 Elevates extracellular adenosine concentration for antiinflammatory and immunosuppressive effects; reaction of imidazole-4-carboxamide with a hydroxyalkylbenzoxazole or benzothiazole compound; 1-[4-hydroxy-1-(2-phenyl-4-benzoxazolyl)-3-pentyl]-imidazole-4-carboxamide |
| 07/21/2005 | US20050159443 For example, N-[2,4-dichloro-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-N-methyl-2-[1-methyl-5-(3-methyl-4-nitro-benzoyl)-1H-pyrrol-2-yl]-acetamide; bradykinin receptor agonists; for treating disorders such as pain, inflammation, asthma and allergy |
| 07/21/2005 | US20050159441 Active ingredient and solvent can be stored separately until apparatus is used in a nebuliser; propellant-free; active ingredient is present in highly-concentrated form for storage purposes; inhalers |
| 07/21/2005 | US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 07/21/2005 | US20050159425 Inducing tolerance to an antigen by administering to patient a prostaglandin or agonist thereof, a phosphodiesterase inhibitor, and antigen or a derivative thereof; suppressing immune system or an inflammatory response; for example, use of misoprostol and rolipram; antiinflammatory agents, antiallergens |
| 07/21/2005 | US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 07/21/2005 | US20050159397 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 07/21/2005 | US20050159386 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050158828 Preparing immunoglobulin dimer for use in prevention and treatment of B cell lymphoma and chronic lymphocytic leukemia; immunotherapeutics |
| 07/21/2005 | US20050158800 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor |
| 07/21/2005 | US20050158721 Using overexpression of senescence-associated genes as diagnostic/prognostic indicator of organ rejection/failure |
| 07/21/2005 | US20050158713 Fitness assay and associated methods |
| 07/21/2005 | US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
| 07/21/2005 | US20050158387 Olopatadine formulations for topical administration |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 07/21/2005 | US20050158314 For treating chronic immune system disorders, inhibiting rejection of transplanted tissue |
| 07/21/2005 | US20050158305 Monoclonal antibody for treatment of cancer, autoimmune diseases and rheumatoid arthritis; complementarity determining regions |
| 07/21/2005 | US20050158302 Methods for diagnosing and treating autoimmune disease |
| 07/21/2005 | US20050158292 Lactococcus induces production of IL-10 from mammalian dendritic or spleen cells; treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer) |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | CA2551399A1 Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/20/2005 | EP1555318A2 Hematopoietic cytokine receptor |
| 07/20/2005 | EP1555031A1 Angiogenesis inducer |
| 07/20/2005 | EP1555028A1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 07/20/2005 | EP1554281A2 Process for preparing certain pyrrolotriazine compounds |
| 07/20/2005 | EP1554265A2 Compounds, compositions and methods |
| 07/20/2005 | EP1554262A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1553970A1 Treatment of allergic conditions by use of il 21 |
| 07/20/2005 | EP1553954A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/20/2005 | EP1553931A1 Compounds, compositions, and methods |
| 07/20/2005 | EP1472251B1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1153931B1 Shortened-chain polynucleotides and process for the preparation thereof |
| 07/20/2005 | EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 07/20/2005 | EP0977586B1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 07/20/2005 | EP0965637B1 Fas ANTIGEN DERIVATIVES |
| 07/20/2005 | CN1643382A A cytocapacity test |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643134A Method for producing pseudo islets |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642973A A method for treating allergies |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 07/20/2005 | CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5) |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642563A Compositions and methods for treatment of skin disorders |
| 07/20/2005 | CN1642554A Benzenesulphonate salt of a morpholine urea derivative for use as a CCR-3 antagonist in the treatment of inflammatory conditions |
| 07/20/2005 | CN1642553A N-{'(2S) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions |
| 07/20/2005 | CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1642437A Probiotic delivery system |
| 07/20/2005 | CN1640890A Cell withering factor derivated from placents |